Mirum Pharmaceuticals (MIRM) Operating Expenses (2019 - 2026)
Mirum Pharmaceuticals (MIRM) posted quarterly Operating Expenses of $949.3 million for Q1 2026, up 648.89% year-over-year from $126.8 million in Q1 2025, and up 518.47% quarter-over-quarter from $153.5 million in Q4 2025.
Mirum Pharmaceuticals (MIRM) Operating Expenses (2019 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Operating Expenses history runs 8 years deep, the most recent figure standing at $949.3 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 648.89% year-over-year to $949.3 million; the TTM figure through Mar 2026 stood at $1.4 billion (up 199.85% YoY), while the FY2025 annual figure was $543.4 million, up 28.02% from the prior year.
- Operating Expenses for Q1 2026 stood at $949.3 million, up from $153.5 million in the prior quarter.
- The five-year high for Operating Expenses was $949.3 million in Q1 2026, with the low at $45.6 million in Q1 2022.
- The 5-year median for Operating Expenses is $102.1 million (2024), against an average of $142.4 million.
- The sharpest annual moves came in 2022 and 2026: Operating Expenses retreated 4.17% in 2022, then surged 648.89% in 2026.
- Mirum Pharmaceuticals' Operating Expenses stood at $62.1 million in 2022, then soared by 64.56% to $102.1 million in 2023, then advanced by 21.05% to $123.6 million in 2024, then rose by 24.15% to $153.5 million in 2025, then soared by 518.47% to $949.3 million in 2026.
- Business Quant data shows MIRM's Operating Expenses at $949.3 million in Q1 2026, $153.5 million in Q4 2025, and $130.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Mirum Pharmaceuticals | 6.52 Bn | 6.08 Bn | 145.90 Mn | 218.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 218.78 Mn |
| Mar 31, 2026 | 949.35 Mn |
| Dec 31, 2025 | 153.50 Mn |
| Sep 30, 2025 | 130.41 Mn |
| Jun 30, 2025 | 132.77 Mn |
| Mar 31, 2025 | 126.77 Mn |
| Dec 31, 2024 | 123.64 Mn |
| Sep 30, 2024 | 103.06 Mn |
| Jun 30, 2024 | 102.11 Mn |
| Mar 31, 2024 | 95.69 Mn |
| Dec 31, 2023 | 102.14 Mn |
| Sep 30, 2023 | 72.87 Mn |
| Jun 30, 2023 | 61.77 Mn |
| Mar 31, 2023 | 58.75 Mn |
| Dec 31, 2022 | 62.07 Mn |
| Sep 30, 2022 | 51.66 Mn |
| Jun 30, 2022 | 48.93 Mn |
| Mar 31, 2022 | 45.63 Mn |
| Dec 31, 2021 | 48.71 Mn |
| Sep 30, 2021 | 47.82 Mn |